Akros Monthly Payout Etf Current Valuation
| MPAY Etf | USD 0.72 22.79 96.95% |
Valuation analysis of Akros Monthly Payout helps investors to measure Akros Monthly's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Akros Monthly's price fluctuation is very steady at this time. Calculation of the real value of Akros Monthly Payout is based on 3 months time horizon. Increasing Akros Monthly's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Akros Monthly Payout is useful when determining the fair value of the Akros etf, which is usually determined by what a typical buyer is willing to pay for full or partial control of Akros Monthly. Since Akros Monthly is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akros Etf. However, Akros Monthly's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.72 | Real 23.47 | Hype 23.51 | Naive 23.33 |
The real value of Akros Etf, also known as its intrinsic value, is the underlying worth of Akros Monthly Payout ETF, which is reflected in its stock price. It is based on Akros Monthly's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Akros Monthly's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Akros Monthly's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Akros Monthly Payout helps investors to forecast how Akros etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akros Monthly more accurately as focusing exclusively on Akros Monthly's fundamentals will not take into account other important factors: Akros Monthly Payout ETF Current Valuation Analysis
Akros Monthly's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Akros Monthly Current Valuation | 1.25 M |
Most of Akros Monthly's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akros Monthly Payout is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Akros Monthly Payout has a Current Valuation of 1.25 M. This is much higher than that of the Cabana family and significantly higher than that of the Moderate Allocation category. The current valuation for all United States etfs is notably lower than that of the firm.
Akros Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akros Monthly's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Akros Monthly could also be used in its relative valuation, which is a method of valuing Akros Monthly by comparing valuation metrics of similar companies.Akros Monthly is currently under evaluation in current valuation as compared to similar ETFs.
Fund Asset Allocation for Akros Monthly
The fund invests most of its assets under management in various types of exotic instruments, with the rest of asset invested in stocks.Asset allocation divides Akros Monthly's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Akros Fundamentals
| Return On Equity | -181.7 | |||
| Return On Asset | -285.95 | |||
| Profit Margin | (260.32) % | |||
| Operating Margin | (234.69) % | |||
| Current Valuation | 1.25 M | |||
| Shares Outstanding | 14.29 M | |||
| Shares Owned By Insiders | 38.95 % | |||
| Price To Earning | (0.69) X | |||
| Price To Book | 60.00 X | |||
| Price To Sales | 0.39 X | |||
| Revenue | 407.98 K | |||
| Gross Profit | 438.28 K | |||
| EBITDA | (954.29 K) | |||
| Net Income | (1.06 M) | |||
| Cash And Equivalents | 23.87 K | |||
| Total Debt | 1.11 M | |||
| Debt To Equity | 247.30 % | |||
| Current Ratio | 0.06 X | |||
| Book Value Per Share | (0.10) X | |||
| Cash Flow From Operations | (475.03 K) | |||
| Earnings Per Share | (4.53) X | |||
| Market Capitalization | 158.56 K | |||
| Total Asset | 2.21 M | |||
| Retained Earnings | (6.33 M) | |||
| Working Capital | (222.36 K) | |||
| Current Asset | 318.83 K | |||
| Current Liabilities | 541.18 K | |||
| One Year Return | 12.10 % | |||
| Net Asset | 2.21 M | |||
| Equity Positions Weight | 4.53 % |
About Akros Monthly Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akros Monthly Payout's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akros Monthly using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akros Monthly Payout based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Akros Monthly Piotroski F Score and Akros Monthly Altman Z Score analysis. Note that the Akros Monthly Payout information on this page should be used as a complementary analysis to other Akros Monthly's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
The market value of Akros Monthly Payout is measured differently than its book value, which is the value of Akros that is recorded on the company's balance sheet. Investors also form their own opinion of Akros Monthly's value that differs from its market value or its book value, called intrinsic value, which is Akros Monthly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akros Monthly's market value can be influenced by many factors that don't directly affect Akros Monthly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akros Monthly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akros Monthly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akros Monthly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.